NDC Compounded Drug 60652-6795-2 Morphine Sulfate
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Morphine Sulfate
NDC crossover of Morphine Sulfate with NDC 60652-6795 a human compounded drug with other similar products matching the same substance name (Morphine Sulfate) and the same administration route (intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
63037-145-25 | Morphine Sulfate | Morphine Sulfate | 2 mL in 1 SYRINGE, PLASTIC | Injection | Intravenous | Hikma Injectables Usa Inc. |
70092-125-48 | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-125-48 | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-128-50 | Morphine 1 Mg/ml 50 Ml Ns Syr | Morphine 1 Mg/ml 50 Ml Ns Syr | 50 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-128-50 | Morphine 1 Mg/ml 50 Ml Ns Syr | Morphine 1 Mg/ml 50 Ml Ns Syr | 50 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-132-43 | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-132-43 | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-132-43 | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-132-43 | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | Morphine Pf 0.5 Mg/ml 2 Ml-3ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-133-43 | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-133-43 | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-133-43 | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-133-43 | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | Morphine Pf 1 Mg/ml 2 Ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-380-36 | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-380-36 | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-380-36 | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-380-36 | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | Morphine Pf 1 Mg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-517-43 | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-517-43 | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-517-43 | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-517-43 | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | Morphine Pf 1 Mg/ml In 1 Ml Ns- 3 Ml Syr | 1 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-518-75 | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | 100 mL in 1 CARTRIDGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-518-75 | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | 100 mL in 1 CARTRIDGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-518-75 | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | 100 mL in 1 CARTRIDGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-518-75 | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | Morphine Pf 1 Mg/ml 100 Ml Ns Cadd Fsff | 100 mL in 1 CARTRIDGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-519-48 | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-519-48 | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | Morphine Pf 1 Mg/ml In 30 Ml Ns Syr | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-520-49 | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-520-49 | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-520-49 | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb | 30 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb?
Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb was assigned by its manufacturer with NDC product code 60652-6795. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb?
The NDC package code 60652-6795-2 was assigned to a 50 mL in 1 SYRINGE, PLASTIC of morphine sulfate administered intravenous via injection.
Who manufactures this product?
Morphine Pf 1 Mg/ml In 30ml Ns- 35 Ml Mb is manufactured by an outsourced facility and labeled by Ssm Hlth St Clare Hosp-fnton. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hikma Injectables USA Inc. and QuVa Pharma, Inc. with NDC product codes 63037-145-25, 70092-125-48, 70092-125-48, 70092-128-50, 70092-128-50, 70092-132-43, 70092-132-43, 70092-132-43, 70092-132-43, 70092-133-43, 70092-133-43, 70092-133-43, 70092-133-43, 70092-380-36, 70092-380-36, 70092-380-36, 70092-380-36, 70092-517-43, 70092-517-43, 70092-517-43, 70092-517-43, 70092-518-75, 70092-518-75, 70092-518-75, 70092-518-75, 70092-519-48, 70092-519-48, 70092-520-49, 70092-520-49 and 70092-520-49.